Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 6,106 | 1,047 | 40 | 139 | 82 |
| Gross Profit | 6,106 | 1,047 | 40 | 139 | 82 |
| Operating Expenses | 86,359 | 100,380 | 95,236 | 85,528 | 80,218 |
| Operating Income | -80,253 | -99,333 | -95,196 | -85,389 | -80,136 |
| Interest Expense | 40,247 | 39,019 | 37,487 | 32,126 | 35,021 |
| Other Income | 34,748 | 3,768 | -1,447 | -115,939 | 19,515 |
| Pre-tax Income | -85,752 | -134,584 | -134,130 | -233,454 | -95,642 |
| Net Income Continuous | -85,752 | -134,584 | -134,130 | -233,414 | -95,642 |
| Minority Interests | -23 | -20 | -21 | -22 | -60 |
| Net Income | $-85,729 | $-134,564 | $-134,109 | $-233,392 | $-95,582 |
| EPS Basic Total Ops | -0.12 | -0.20 | -0.20 | -0.37 | -0.19 |
| EPS Basic Continuous Ops | -0.12 | -0.20 | -0.20 | -0.37 | -0.19 |
| EPS Diluted Total Ops | -0.14 | -0.20 | -0.20 | -0.37 | -0.19 |
| EPS Diluted Continuous Ops | -0.12 | -0.20 | -0.20 | -0.37 | -0.19 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.20 | -0.20 | N/A | N/A |
| EBITDA(a) | $-69,599 | $-88,604 | $-85,583 | $-72,805 | $-64,113 |